
Lei Yao
Examiner (ID: 12775, Phone: (571)272-3112 , Office: P/1642 )
| Most Active Art Unit | 1642 |
| Art Unit(s) | 1642 |
| Total Applications | 1328 |
| Issued Applications | 662 |
| Pending Applications | 127 |
| Abandoned Applications | 552 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7509973
[patent_doc_number] => 20110256139
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-20
[patent_title] => 'Therapeutic Uses Of Monoclonal Antibodies To The Angiotensin-II Type 1 Receptor'
[patent_app_type] => utility
[patent_app_number] => 13/087770
[patent_app_country] => US
[patent_app_date] => 2011-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5474
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0256/20110256139.pdf
[firstpage_image] =>[orig_patent_app_number] => 13087770
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/087770 | Therapeutic uses of monoclonal antibodies to the angiotensin-II type 1 receptor | Apr 14, 2011 | Issued |
Array
(
[id] => 8963479
[patent_doc_number] => 20130203081
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-08
[patent_title] => 'TUMOR CELL-DERIVED MICROVESICLES'
[patent_app_type] => utility
[patent_app_number] => 13/641085
[patent_app_country] => US
[patent_app_date] => 2011-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 16138
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13641085
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/641085 | TUMOR CELL-DERIVED MICROVESICLES | Apr 12, 2011 | Abandoned |
Array
(
[id] => 9889119
[patent_doc_number] => 08975375
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-03-10
[patent_title] => 'Identification of tumor-associated antigens for diagnosis and therapy'
[patent_app_type] => utility
[patent_app_number] => 13/086176
[patent_app_country] => US
[patent_app_date] => 2011-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 46
[patent_figures_cnt] => 40
[patent_no_of_words] => 23542
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13086176
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/086176 | Identification of tumor-associated antigens for diagnosis and therapy | Apr 12, 2011 | Issued |
Array
(
[id] => 7777223
[patent_doc_number] => 20120040356
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-16
[patent_title] => 'Methods for Detecting Oncofetal Fibronectin'
[patent_app_type] => utility
[patent_app_number] => 13/081826
[patent_app_country] => US
[patent_app_date] => 2011-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 165191
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0040/20120040356.pdf
[firstpage_image] =>[orig_patent_app_number] => 13081826
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/081826 | Methods for detecting oncofetal fibronectin | Apr 6, 2011 | Issued |
Array
(
[id] => 8708639
[patent_doc_number] => 20130065928
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-14
[patent_title] => 'BIOMARKERS FOR PI3K-DRIVEN CANCER'
[patent_app_type] => utility
[patent_app_number] => 13/638925
[patent_app_country] => US
[patent_app_date] => 2011-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 7564
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13638925
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/638925 | BIOMARKERS FOR PI3K-DRIVEN CANCER | Apr 1, 2011 | Abandoned |
Array
(
[id] => 6046729
[patent_doc_number] => 20110206691
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-25
[patent_title] => 'Methods and Compositions for Treating Neuroblastoma'
[patent_app_type] => utility
[patent_app_number] => 13/072090
[patent_app_country] => US
[patent_app_date] => 2011-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 40
[patent_no_of_words] => 27606
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0206/20110206691.pdf
[firstpage_image] =>[orig_patent_app_number] => 13072090
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/072090 | Methods and Compositions for Treating Neuroblastoma | Mar 24, 2011 | Abandoned |
Array
(
[id] => 9299603
[patent_doc_number] => 08647826
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-02-11
[patent_title] => 'Nucleic acid and corresponding protein entitled 125P5C8 useful in treatment and detection of cancer'
[patent_app_type] => utility
[patent_app_number] => 13/052002
[patent_app_country] => US
[patent_app_date] => 2011-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 46
[patent_figures_cnt] => 49
[patent_no_of_words] => 114057
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13052002
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/052002 | Nucleic acid and corresponding protein entitled 125P5C8 useful in treatment and detection of cancer | Mar 17, 2011 | Issued |
Array
(
[id] => 8637554
[patent_doc_number] => 20130029357
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-31
[patent_title] => 'DIAGNOSTIC MARKER FOR EFFECT OF ANTICANCER AGENT'
[patent_app_type] => utility
[patent_app_number] => 13/635911
[patent_app_country] => US
[patent_app_date] => 2011-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6072
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13635911
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/635911 | Diagnostic marker for effect of anticancer agent | Mar 17, 2011 | Issued |
Array
(
[id] => 6174422
[patent_doc_number] => 20110177103
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-21
[patent_title] => 'COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMOR'
[patent_app_type] => utility
[patent_app_number] => 13/045722
[patent_app_country] => US
[patent_app_date] => 2011-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 45
[patent_figures_cnt] => 45
[patent_no_of_words] => 79603
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0177/20110177103.pdf
[firstpage_image] =>[orig_patent_app_number] => 13045722
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/045722 | Compositions and methods for the diagnosis and treatment of tumor | Mar 10, 2011 | Issued |
Array
(
[id] => 6101656
[patent_doc_number] => 20110165148
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-07
[patent_title] => 'NUCLEIC ACID AND CORRESPONDING PROTEIN ENTITLED 162P1E6 USEFUL IN TREATMENT AND DETECTION OF CANCER'
[patent_app_type] => utility
[patent_app_number] => 13/043221
[patent_app_country] => US
[patent_app_date] => 2011-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 87
[patent_figures_cnt] => 87
[patent_no_of_words] => 72174
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0165/20110165148.pdf
[firstpage_image] =>[orig_patent_app_number] => 13043221
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/043221 | Nucleic acid and corresponding protein entitled 162P1E6 useful in treatment and detection of cancer | Mar 7, 2011 | Issued |
Array
(
[id] => 6101693
[patent_doc_number] => 20110165185
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-07
[patent_title] => 'IMMUNOGENIC PEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 13/038794
[patent_app_country] => US
[patent_app_date] => 2011-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 21583
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0165/20110165185.pdf
[firstpage_image] =>[orig_patent_app_number] => 13038794
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/038794 | Immunogenic peptides | Mar 1, 2011 | Issued |
Array
(
[id] => 9922613
[patent_doc_number] => 08980570
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-03-17
[patent_title] => 'Composition for cancer prognosis prediction comprising anti-TMAP/CKAP2 antibodies'
[patent_app_type] => utility
[patent_app_number] => 13/577126
[patent_app_country] => US
[patent_app_date] => 2011-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 14011
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 151
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13577126
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/577126 | Composition for cancer prognosis prediction comprising anti-TMAP/CKAP2 antibodies | Jan 31, 2011 | Issued |
Array
(
[id] => 9523575
[patent_doc_number] => 08747833
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-06-10
[patent_title] => 'B7-H1 and methods of diagnosis, prognosis, and treatment of cancer'
[patent_app_type] => utility
[patent_app_number] => 13/012063
[patent_app_country] => US
[patent_app_date] => 2011-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 12779
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13012063
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/012063 | B7-H1 and methods of diagnosis, prognosis, and treatment of cancer | Jan 23, 2011 | Issued |
Array
(
[id] => 6001702
[patent_doc_number] => 20110117572
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-19
[patent_title] => 'Antibody Specific to the AIMP2-DX2'
[patent_app_type] => utility
[patent_app_number] => 13/011386
[patent_app_country] => US
[patent_app_date] => 2011-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 41
[patent_figures_cnt] => 41
[patent_no_of_words] => 21715
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0117/20110117572.pdf
[firstpage_image] =>[orig_patent_app_number] => 13011386
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/011386 | Antibody Specific to the AIMP2-DX2 | Jan 20, 2011 | Abandoned |
Array
(
[id] => 8585603
[patent_doc_number] => 20130004424
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-03
[patent_title] => 'METHODS FOR DETERMINING AGENTS TARGETING MENA ISOFORMS AND USES THEREOF FOR DIAGNOSIS AND TREATMENT OF METASTATIC TUMORS'
[patent_app_type] => utility
[patent_app_number] => 13/575359
[patent_app_country] => US
[patent_app_date] => 2011-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 5548
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13575359
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/575359 | METHODS FOR DETERMINING AGENTS TARGETING MENA ISOFORMS AND USES THEREOF FOR DIAGNOSIS AND TREATMENT OF METASTATIC TUMORS | Jan 18, 2011 | Abandoned |
Array
(
[id] => 8909413
[patent_doc_number] => 08481477
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-07-09
[patent_title] => 'Methods, agents and peptides for inducing an immune response to matrix metalloproteinase-2 expressing tumors'
[patent_app_type] => utility
[patent_app_number] => 12/930592
[patent_app_country] => US
[patent_app_date] => 2011-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 44
[patent_no_of_words] => 28988
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12930592
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/930592 | Methods, agents and peptides for inducing an immune response to matrix metalloproteinase-2 expressing tumors | Jan 10, 2011 | Issued |
Array
(
[id] => 6083669
[patent_doc_number] => 20110144034
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-16
[patent_title] => 'INHIBITION OF TUMOR METASTASES USING PROTEIN KINASE C (PKC) INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 12/976873
[patent_app_country] => US
[patent_app_date] => 2010-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 11014
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0144/20110144034.pdf
[firstpage_image] =>[orig_patent_app_number] => 12976873
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/976873 | INHIBITION OF TUMOR METASTASES USING PROTEIN KINASE C (PKC) INHIBITORS | Dec 21, 2010 | Abandoned |
Array
(
[id] => 6102602
[patent_doc_number] => 20110166095
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-07
[patent_title] => 'CANCER PLATINUM RESISTANCE DETECTION AND SENSITIZATION METHOD'
[patent_app_type] => utility
[patent_app_number] => 12/975970
[patent_app_country] => US
[patent_app_date] => 2010-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 7413
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20110166095.pdf
[firstpage_image] =>[orig_patent_app_number] => 12975970
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/975970 | Cancer platinum resistance detection and sensitization method | Dec 21, 2010 | Issued |
Array
(
[id] => 5977520
[patent_doc_number] => 20110154522
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-23
[patent_title] => 'BH3 Peptides And Method Of Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 12/966821
[patent_app_country] => US
[patent_app_date] => 2010-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 21574
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0154/20110154522.pdf
[firstpage_image] =>[orig_patent_app_number] => 12966821
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/966821 | BH3 peptides and method of use thereof | Dec 12, 2010 | Issued |
Array
(
[id] => 8054077
[patent_doc_number] => 20120076775
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-29
[patent_title] => 'Combination of HGF Inhibitor and EGF Inhibitor to Treat Cancer'
[patent_app_type] => utility
[patent_app_number] => 12/963595
[patent_app_country] => US
[patent_app_date] => 2010-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 10186
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20120076775.pdf
[firstpage_image] =>[orig_patent_app_number] => 12963595
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/963595 | Combination of HGF Inhibitor and EGF Inhibitor to Treat Cancer | Dec 7, 2010 | Abandoned |